130 related articles for article (PubMed ID: 37526109)
1. Preferences of people living with HIV for injectable and oral antiretroviral treatment in the Netherlands: a discrete choice experiment.
Kremer IEH; Beaudart C; Simons J; Plieger H; Schroeder M; Hiligsmann M
AIDS Care; 2024 Apr; 36(4):536-545. PubMed ID: 37526109
[No Abstract] [Full Text] [Related]
2. Patient and Physician Preferences for Regimen Attributes for the Treatment of HIV in the United States and Canada.
Gelhorn H; Garris C; Arthurs E; Spinelli F; Cutts K; Chua GN; Collacott H; Lebouché B; Lowman E; Rice H; Heidenreich S
J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330334
[TBL] [Abstract][Full Text] [Related]
3. Preferences of People Living with HIV for Long-Acting Antiretroviral Treatment in Germany: Evidence from a Discrete Choice Experiment.
Emmert M; Rohrbacher S; Jahn J; Fernando K; Lauerer M
Patient; 2023 Sep; 16(5):537-553. PubMed ID: 37436659
[TBL] [Abstract][Full Text] [Related]
4. Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people living with HIV in Japan and its associated factors: a prospective multicenter cross-sectional observational study.
Ishihara M; Hikasa S; Tsukiji M; Kunimoto Y; Nobori K; Kimura T; Onishi K; Yamamoto Y; Haruta K; Kashiwabara Y; Fujii K; Shimabukuro S; Watanabe D; Tsurumi H; Suzuki A
AIDS Res Ther; 2023 Aug; 20(1):62. PubMed ID: 37641099
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment.
Ostermann J; Mühlbacher A; Brown DS; Regier DA; Hobbie A; Weinhold A; Alshareef N; Derrick C; Thielman NM
Value Health; 2020 Jul; 23(7):851-861. PubMed ID: 32762986
[TBL] [Abstract][Full Text] [Related]
6. U.S. patient preferences for long-acting HIV treatment: a discrete choice experiment.
Graham SM; Barthold D; Hauber B; Brah AT; Saldarriaga E; Collier AC; Ho RJY; ; Marconi VC; Simoni JM
J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26099. PubMed ID: 37439051
[TBL] [Abstract][Full Text] [Related]
7. Understanding Treatment Preferences Among People Living with HIV in Australia: A Discrete Choice Experiment.
Fifer S; Kularatne T; Tan M; Drummond F; Rule J
Patient Prefer Adherence; 2023; 17():1825-1843. PubMed ID: 37525842
[TBL] [Abstract][Full Text] [Related]
8. Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV.
Simoni JM; Beima-Sofie K; Mohamed ZH; Christodoulou J; Tapia K; Graham SM; Ho R; Collier AC
AIDS Patient Care STDS; 2019 Mar; 33(3):104-111. PubMed ID: 30844308
[TBL] [Abstract][Full Text] [Related]
9. Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability.
Fletcher L; Burrowes SAB; Khan GK; Sabin L; Johnson S; Kimmel SD; Ruiz-Mercado G; Pierre C; Drainoni ML
Harm Reduct J; 2023 Jan; 20(1):4. PubMed ID: 36627679
[TBL] [Abstract][Full Text] [Related]
10. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV.
Matza LS; Paulus TM; Garris CP; Van de Velde N; Chounta V; Deger KA
Patient; 2020 Aug; 13(4):409-422. PubMed ID: 32356146
[TBL] [Abstract][Full Text] [Related]
11. Preference for long-acting injectable for ART and PrEP among people with and without HIV: a cross-sectional study in Argentina.
Sciannameo S; Zalazar V; Spadaccini L; Duarte M; Cahn P; Aristegui I; Sued O
Ther Adv Infect Dis; 2024; 11():20499361241228341. PubMed ID: 38380160
[TBL] [Abstract][Full Text] [Related]
12. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.
Dubé K; Campbell DM; Perry KE; Kanazawa JT; Saberi P; Sauceda JA; Poteat T; Evans D
AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1054-1058. PubMed ID: 32829645
[TBL] [Abstract][Full Text] [Related]
13. Implementing long-acting injectable antiretroviral treatments in Senegal: issues, challenges and conditions for introducing them. Qualitative study with healthcare providers and patients.
Carillon S; Laborde-Balen G; Diop M; Diop K; Breton G; Ndiaye B; Taverne B
AIDS Care; 2024 May; 36(5):703-709. PubMed ID: 37708454
[TBL] [Abstract][Full Text] [Related]
14. Perceptions of Long-Acting Injectable Antiretroviral Therapy Among People Living with HIV Who Use Drugs and Service Providers: a Qualitative Analysis in Rhode Island.
Collins AB; Macon EC; Langdon K; Joseph R; Thomas A; Dogon C; Beckwith CG
J Urban Health; 2023 Oct; 100(5):1062-1073. PubMed ID: 37563518
[TBL] [Abstract][Full Text] [Related]
15. A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.
Simoni JM; Tapia K; Lee SJ; Graham SM; Beima-Sofie K; Mohamed ZH; Christodoulou J; Ho R; Collier AC
AIDS Behav; 2020 Apr; 24(4):1226-1236. PubMed ID: 31655915
[TBL] [Abstract][Full Text] [Related]
16. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
Dubé K; Eskaf S; Evans D; Sauceda J; Saberi P; Brown B; Averitt D; Martel K; Meija M; Campbell D; Barr L; Kanazawa J; Perry K; Patel H; Luter S; Poteat T; Auerbach JD; Wohl DA
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):324-348. PubMed ID: 31608651
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention: understanding potential users' ambivalences.
Carillon S; Gallardo L; Linard F; Chakvetadze C; Viard JP; Cros A; Molina JM; Slama L
AIDS Care; 2020 May; 32(sup2):155-161. PubMed ID: 32189506
[TBL] [Abstract][Full Text] [Related]
18. Patient Education and Decision Support for Long-Acting Injectable HIV Antiretroviral Therapy: Protocol for Tool Development and Pilot Testing with Ryan White HIV/AIDS Program Medical Case Management Programs in New York.
Irvine MK; Zimba R; Avoundjian T; Peterson M; Emmert C; Kulkarni SG; Philbin MM; Kelvin EA; Nash D
JMIR Res Protoc; 2024 Mar; 13():e56892. PubMed ID: 38536227
[TBL] [Abstract][Full Text] [Related]
19. Variation in Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among US Men Who Have Sex with Men: A Latent Class Analysis.
Beckham SW; Sanchez T; Fowler R; Zlotorzynska M; Rai M; Sullivan P; Vannappagari V; Sarkar S; Glick JL; Rinehart AR; Rawlings K; Bridges JFP
AIDS Patient Care STDS; 2023 Oct; 37(10):495-503. PubMed ID: 37862078
[TBL] [Abstract][Full Text] [Related]
20. Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States.
McCrimmon T; Collins LF; Perez-Brumer A; Bazzi AR; Shaffer VA; Kerrigan D; Alcaide ML; Philbin MM
AIDS Patient Care STDS; 2024 Feb; 38(2):61-69. PubMed ID: 38381949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
